Vedolizumab for induction and maintenance of remission in ulcerative colitis
about
Oral budesonide for induction of remission in ulcerative colitisEtrolizumab for induction of remission in ulcerative colitisEtrolizumab for induction of remission in ulcerative colitisVedolizumab for induction and maintenance of remission in Crohn’s diseaseAnti-MAdCAM antibody for induction of remission in ulcerative colitisPatient considerations in the management of ulcerative colitis - role of vedolizumabAdvances in refractory ulcerative colitis treatment: A new therapeutic target, Annexin A2Review article: the practical management of acute severe ulcerative colitis.Immunogenetic Pathogenesis of Celiac Disease and Non-celiac Gluten Sensitivity.Cost-effectiveness of adalimumab, infliximab or vedolizumab as first-line biological therapy in moderate-to-severe ulcerative colitisEmerging biologics in inflammatory bowel disease.Insulin resistance in vascular endothelial cells promotes intestinal tumour formationThe Effect of Antidepressants on the Course of Inflammatory Bowel Disease
P2860
Q24186368-9DB52BD4-9E13-49A9-B1BD-D21300073E96Q24186788-7E455F43-A88F-4797-9087-DDE9B9706624Q24187269-B6B1BA8A-E43F-40F4-A3CF-0B227F1705CDQ24187571-16EF8A25-0549-4EF2-BA30-03D0847038D2Q24187593-95E6B40A-0AC4-44F0-966A-D02D5B24307FQ26796432-490A5D97-862B-4CCA-A894-3B4CB18D704EQ26798299-121B4BE0-2751-47A5-9399-354C1946148FQ35883580-247BB451-6DCE-4697-8E5F-D7B6CEE003E2Q36027518-9D9AAFB1-30D9-4526-BE1A-FE12ACBDCC09Q36882311-31D4A1AE-FD7F-43E7-AF17-DD3F9C5748C2Q39004625-7C37DB76-CA84-476D-9888-17277DEB21F8Q42775323-2CDFF5AF-1EE4-4118-897E-7876613A7237Q57115337-90214396-FA1A-4201-A9C6-A0909D8D28B8
P2860
Vedolizumab for induction and maintenance of remission in ulcerative colitis
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Vedolizumab for induction and maintenance of remission in ulcerative colitis
@ast
Vedolizumab for induction and maintenance of remission in ulcerative colitis
@en
Vedolizumab for induction and maintenance of remission in ulcerative colitis
@en-gb
Vedolizumab for induction and maintenance of remission in ulcerative colitis
@nl
type
label
Vedolizumab for induction and maintenance of remission in ulcerative colitis
@ast
Vedolizumab for induction and maintenance of remission in ulcerative colitis
@en
Vedolizumab for induction and maintenance of remission in ulcerative colitis
@en-gb
Vedolizumab for induction and maintenance of remission in ulcerative colitis
@nl
prefLabel
Vedolizumab for induction and maintenance of remission in ulcerative colitis
@ast
Vedolizumab for induction and maintenance of remission in ulcerative colitis
@en
Vedolizumab for induction and maintenance of remission in ulcerative colitis
@en-gb
Vedolizumab for induction and maintenance of remission in ulcerative colitis
@nl
P2093
P2860
P3181
P1476
Vedolizumab for induction and maintenance of remission in ulcerative colitis
@en
P2093
Brian W Behm
David J Tsoulis
Jianfeng Cheng
John K MacDonald
Reena Khanna
Stephen J Bickston
P2860
P3181
P356
10.1002/14651858.CD007571.PUB2
P577
2014-08-08T00:00:00Z